We use cookies and analytics tools to improve the user experience on the Internet site and for marketing purposes. If you continue to use this site, we will assume that you agree. To the privacy policy.
Treats and limits the recurrence of eczema lesions.
Dexyane Med Eyelid Cream is a medical product* for the treatment of atopic dermatitis or contact eczema on the eyelids. The highly moisturising formula acts like a plaster that provides relief and reduces swelling on one hand, while on the other hand restoring the skin barrier and limiting bacterial adhesion. Clinically proven effectiveness and good tolerability. Alone, in combination with, or after dermocorticosteroids for the treatment of eczema lesions and to limit their recurrence.
Benefits:
Provides immediate relief and has a decongestant effect.
Restores the compromised skin barrier and corrects dryness thanks to a combination of glycerin, shea butter, and triglycerides.
Protects the skin with a semi-occlusive protective film made from a polysaccharide network.
Limits bacterial adhesion (S. aureus is potentially involved in the superinfection of lesions).
*Dexyane Med Eyelid Cream is a medical product that meets the legal requirements of the EU Regulation on Medical Devices and is therefore marked with the CE label. Please read the instructions in the package leaflet carefully. Do not use during pregnancy or breastfeeding. Avoid direct contact with the eyes. From the age of 3 months.
Expert advice by a pharmacist: info@haar-shop.ch / 033 550 30 30 (Mon – Fri | 08:00 – 18:00)
Product characteristics
Brand
Ducray
Ingredients
fragrance-freeGlycerinShea butter
Care
Hydrationcalmingdermatologically tested
Skin type
sensitivedry
Pharmacode
1100586
How to use
Apply twice daily in a thin layer with a clean finger directly to inflammatory lesions of the eyelid, avoiding contact with the eye. For external use only.
Alone, in combination with and/or after dermocorticosteroids.
When combined with a dermocorticosteroid, apply the dermocorticosteroid and wait a few minutes (5–15 minutes) before applying Dexyane Med eyelid cream.
Consult your doctor regarding the use of Dexyane Med eyelid cream with the prescribed dermocorticosteroid in infants ≥ 3 months and children.
If symptoms do not disappear after three weeks of treatment, a doctor should be consulted.
https://www.haar-shop.ch/en/60079912-deyxane-med-palp-bral-15ml.html?___store=en82916Dexyane Med eyelid creamhttps://cdn.haarshop.ch/catalog/product/thumbnail/a64219eaca421493e4a96a2e983e8d6d6237f116504ed46287024679/small_image/0/448x448/001/99/b/9/b99249421fb4cfecd297473e8d0b07acb6bc1d58_3282770394122_bi_ducray_dexyane_med_augenlidcreme.jpg26.926.9CHFInStock/Brands/Care/Care/Facial care/Care/Facial care/Eye care/Dermatology/Dermatology/Face/Dermatology/Face/Eye care/Brands/Ducray/Brands/Ducray/Eczema2918997197527002701270755025529121899712700270195502<p><strong>Treats</strong> and <strong>limits</strong> the recurrence of <strong>eczema lesions</strong>.</p>
<p>Dexyane Med Eyelid Cream is a medical product* for the treatment of <strong>atopic dermatitis</strong> or <strong>contact eczema</strong> on the eyelids. The highly moisturising formula acts like a plaster that provides <strong>relief</strong> and <strong>reduces swelling</strong> on one hand, while on the other hand <strong>restoring the skin barrier</strong> and limiting bacterial adhesion. Clinically proven effectiveness and good tolerability. Alone, in combination with, or after dermocorticosteroids for the treatment of eczema lesions and to limit their recurrence.</p>
<p> </p>
<p><strong>Benefits:</strong></p>
<ul>
<li>Provides immediate relief and has a decongestant effect.</li>
<li>Restores the compromised skin barrier and corrects dryness thanks to a combination of glycerin, shea butter, and triglycerides.</li>
<li>Protects the skin with a semi-occlusive protective film made from a polysaccharide network.</li>
<li>Limits bacterial adhesion (S. aureus is potentially involved in the superinfection of lesions).</li>
</ul>
<p> </p>
<p> </p>
<p><em>*Dexyane Med Eyelid Cream is a medical product that meets the legal requirements of the EU Regulation on Medical Devices and is therefore marked with the CE label. Please read the instructions in the package leaflet carefully. Do not use during pregnancy or breastfeeding. Avoid direct contact with the eyes. From the age of 3 months.</em></p><div><br></div><div><img src="data:image/png;base64,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" data-filename="download.png" style="width: 33px;"> <strong>Expert advice by a pharmacist:<a href="mailto:%20info@haar-shop.ch" target="_blank"> info@haar-shop.ch</a> / 033 550 30 30</strong> (Mon – Fri | 08:00 – 18:00)<br></div>DucrayCHF00https://cdn.haarshop.ch/catalog/product/1/b/1b845fb4b8d226d1b1f1b26e76211a494248f78d_3282770394122_ai_ducray_dexyane_med_augenlidcreme_1.jpghttps://cdn.haarshop.ch/catalog/product/4/0/401981ef11b5230e2d219bdee319fe09d49dba8f_3282770394122_ai_ducray_dexyane_med_augenlidcreme_2.jpgadd-to-cartsku:60079912not_in_nosto:Nodd_deal:dd_items:0dd_from:dd_initialAmount:dd_to:dd_price:dd_displayType:badge_counterhttps://cdn.haarshop.ch/catalog/product/thumbnail/0392d727ebb63291eec42a6703181f338364cb7910905fa6ce0212a6/small_image/0/224x224/001/99/b/9/b99249421fb4cfecd297473e8d0b07acb6bc1d58_3282770394122_bi_ducray_dexyane_med_augenlidcreme.jpgNo60079912Eye creamDexyane Med eyelid creamDucray26.90000011005863282770394122NoNo15 ml< 20 mlsensitive, dryHydration, calming, dermatologically testedfragrance-free, Glycerin, Shea butter552902024-12-23 00:00:002025-02-23 00:00:00YesYessimple
We ship with
Payment
Invoice
Cash in advance
Responsibility
Compensated CO2 emission by haar-shop.ch: 1'100'000 kg
Expert advice by a pharmacist:
